GeekWire

FEBRUARY 8, 2021

Nautilus Biotechnology co-founders Sujal Patel (left) and Parag Mallick. Nautilus Biotechnology , a Seattle-based biotech startup led by Isilon co-founder Sujal Patel , is the latest company to go public using a special purpose acquisition company, or SPAC. Nautilus Photo). It values the company at $900 million.

Biotechnology 145

Biotechnology .Net Groups Company 145

GeekWire

OCTOBER 19, 2021

Sana Biotechnology has a new $50 million tool in its toolbox. Beam may also receive additional payments, for instance upon the achievement of development and sales milestones. Sana aims to develop therapeutics for conditions as diverse as cancer, diabetes and cardiovascular disorders. Sana CEO and president Steve Harr.

Biotechnology 133

Biotechnology System Programming Engineering 133

GeekWire

OCTOBER 10, 2023

Sana Biotechnology will reduce its workforce by 29%, the Seattle-based cell and gene therapy company revealed in a SEC filing Tuesday. Sana, which went public in 2021, said it will continue development of its manufacturing facility in Bothell, Wash. Sana previously cut 15% of its staff in November. The company said it had $325.9

Biotechnology 102

Biotechnology .Net Report Company 102

GeekWire

JUNE 9, 2021

Nautilus Biotechnology co-founders Sujal Patel (left) and Parag Mallick. Nautilus Biotechnology is emerging as Seattle’s newest publicly traded company this week, taking advantage of the mania over SPACs to raise $345 million to fuel a new approach that could accelerate biomedical research and transform drug development.

Biotechnology 129

Biotechnology Analysis Research Engineering 129

GeekWire

JULY 7, 2021

The company, a spin-out from the UW’s Institute for Protein Design , is developing vaccines to resemble naturally occurring viruses. Icosavax is also developing shots, geared for older adults, against two viruses that cause pneumonia, respiratory syncytial virus (RSV) and human metapneumovirus (hMPV).

Development 142

Development Biotechnology Pharmaceuticals .Net 142

GeekWire

JULY 14, 2020

Adaptive Biotechnologies announced Tuesday that it will sell 8 million shares of its common stock — 6 million of its own, and 2 million from an investor — to help accelerate the company’s work.

Biotechnology 70

Biotechnology Development Microsoft Report 70

GeekWire

JULY 2, 2020

OncoSenX is the spinoff of a third company, Seattle-based Oisin Biotechnologies. The researchers said they have selected the two most promising DNA sequences for further testing. Researchers at OncoSenX are using Fusogenix for cancer research on the treatment of solid tumors.

Research 145

Research Pharmaceuticals Biotechnology Development 145

GeekWire

JUNE 11, 2024

Levitate Bio’s CEO Sam DeLuca, left, and Karen Khar, executive vice president of sales and business development. David Baker, director of the UW’s Institute for Protein Design, runs the lab that developed Rosetta and is an advocate for open-source tools. Tech companies are really good at what they do.

Software 115

Software Software Development Company 115

GeekWire

AUGUST 12, 2024

To make a profit, yes, but also to support the development of technologies needed to sustain settlements on the Red Planet. (NASA Photo / Dominic Hart) The Mars Society says it’s making progress on launching a startup incubator in the Seattle area, with artificial intelligence and biotech as its first targets. Its long-term goal?

Biotechnology 126

Biotechnology Chemicals Engineering Artificial Intelligence 126

GeekWire

SEPTEMBER 1, 2020

Lumen Bioscience today announced a $16 million Series B round to help support its novel approach to rapid and low-cost drug development. Lumen is led by Finrow, a former senior vice president at Adaptive Biotechnologies, and Chief Science Officer Jim Roberts , the former head of basic sciences at the Fred Hutchinson Cancer Research Institute.

Development 133

Development Biotechnology Travel Programming 133

CIO Business Intelligence

JUNE 2, 2022

Using HPC from the University of Cambridge, researchers are creating a new method of machine learning whereby the computer ‘learns how to learn’—which could advance studies in drug development and disease treatment. A team from the UK, Sweden, India, and the Netherlands developed the approach, known as transformational machine learning (TML).

Dell 355

Dell Intel Artificial Intelligence Energy 355

GeekWire

NOVEMBER 10, 2020

Adaptive Biotechnologies CEO Chad Robins. Adaptive Biotechnologies beat expectations for its fiscal third quarter as the Seattle company continues to use its immune medicine platform in the fight against COVID-19. The company also is developing T-Detect COVID , a T-cell-based test for identifying past COVID-19 infections.

Biotechnology 74

Biotechnology Pharmaceuticals Development System 74

GeekWire

MAY 21, 2020

The 4-year-old company is developing cytokines that regulate their own activity in response to biomarkers and metabolic signals, said CEO John Mulligan. Another Seattle biotech company, Nautilus Biotechnology, announced a $76 million funding round Thursday. It is focused initially on immuno-oncology applications.

Development 109

Development Biotechnology Microsoft Applications 109

GeekWire

DECEMBER 20, 2021

Alexandria Real Equities , a life sciences real estate developer, has bought a 5.2-acre Alexandria bought the property from Bellevue company Pine Forest, which has been planning a large mixed-use development for the site. Alexandria is developing a life sciences hub at Seattle’s almost three-acre Mercer Mega Block.

Real Estate 120

Real Estate Development Biotechnology Journal 120

CIO Business Intelligence

JUNE 22, 2023

While Silicon Valley still pays top dollar for IT pros, the war for talent has moved beyond the technology industry, with other verticals vying for talented IT workers who have the skills to enable digital transformation, process improvement, change management, and the development of apps and services.

Industry 306

Industry Project Management Quality Assurance Insurance 306

GeekWire

JULY 27, 2020

Chad Robins, CEO of Adaptive Biotechnologies, speaks at the site of the company’s future corporate headquarters in Seattle, standing in front of the final piece of structural steel before it’s put into place. Stephen Brashear/AP Images for Adaptive Biotechnologies). Stephen Brashear/AP Images for Adaptive Biotechnologies).

Biotechnology 127

Biotechnology Real Estate Industry Microsoft 127

CIO Business Intelligence

MAY 31, 2022

Throwing light on the digital adoption challenges, Rath says, “In the pharma industry doctors are involved only after a drug’s development and approvals are completed, which works just fine. Doctors are not involved in the development of a solution right from the start. Digital healthcare, however, is a different ball game.

Healthcare 287

Healthcare Biotechnology Artificial Intelligence Research 287

Dataconomy

FEBRUARY 7, 2025

LG AI Research has partnered with Seoul National University to develop an artificial intelligence model for predicting multistate protein structures, aiming to enhance drug discovery and disease research. Baek previously co-developed “RoseTTAFold” with Prof. Min-Kyung Baek, a specialist in protein structure prediction.

Research 41

Research Development Healthcare Biotechnology 41

GeekWire

AUGUST 26, 2021

Diagnostics startup ID Genomics will accelerate its development of a quick test for variants of the COVID-19 virus with a new grant from the U.S. In addition to developing the CovNET rapid test, ID Genomics will launch a next-day sequencing service for variants within the next few weeks. National Institutes of Health.

Development 129

Development Biotechnology Small Business Analysis 129

GeekWire

NOVEMBER 19, 2020

Umoja Biopharma raised $53 million to expand development of its CAR T-cell immunotherapy treatments for blood-based and organ-based tumors in adult and pediatric patients. ” Umoja is one of several companies in the Seattle region developing immunotherapy-related technologies. Umoja Biopharma CEO Andy Scharenberg. Umoja Photo).

Biotechnology 145

Biotechnology Research CTO Development 145

GeekWire

JULY 29, 2021

The company, a spin-out from the University of Washington’s Institute for Protein Design , is developing vaccines to resemble naturally occurring viruses. Icosavax is also developing shots, geared for older adults, against two viruses that cause pneumonia, respiratory syncytial virus (RSV) and human metapneumovirus (hMPV).

Biotechnology 139

Biotechnology Company Pharmaceuticals Research 139

CIO Business Intelligence

FEBRUARY 19, 2025

One of the biggest pain points for organizations when they want to go towards AI development is that the most valuable data they own, most often the customer data, is locked away due to the [EU] GDPR or other privacy laws, she says. Another example comes from Poolside, an AI developer focused on software engineering.

Training 254

Training Data Software Development Biotechnology 254

GeekWire

JUNE 30, 2021

based company developing technologies to accelerate the process of drug discovery, announced today that it plans to go public via an IPO. Absci aims to circumvent current processes for developing protein-based drugs, which often require manufacture in mammalian cells, a cumbersome and difficult method. Absci Photo).

Company 132

Company Biotechnology .Net Programming 132

GeekWire

JUNE 23, 2020

Sana Biotechnology today formally announced that it has raised more than $700 million in venture funding — one of the largest venture financing deals in the life sciences industry and one of the biggest rounds on record in Seattle. Steve Harr (Sana Photo). Its executive chairman is Hans Bishop , the former CEO of Juno.

Development 102

Development Company Biotechnology Research 102

GeekWire

APRIL 15, 2021

Chad Robins, left, is co-founder and CEO of Adaptive Biotechnologies, which he co-founded with his brother, Harlan Robins, right, a theoretical physicist turned computational biologist who is the company’s chief scientific officer. Adaptive Biotechnologies Photo).

Biotechnology 108

Biotechnology Education Web Services Insurance 108

CIO Business Intelligence

SEPTEMBER 18, 2023

According to the 2023 State of the CIO , IT leaders are looking to shore up competencies in key areas such as cybersecurity (39%), application development (30%), data science/analytics (30%), and AI/machine learning (26%). From an individual’s perspective, it keeps careers interesting and helps people grow with the organization.

Pharmaceuticals 340

Pharmaceuticals Training Programming SAP 340

TechSpot

JULY 24, 2024

The UK Space Agency and BiologIC Technologies are partnering to develop advanced biotechnologies, including vaccines and gene therapies, for space manufacturing.

Biotechnology 101

Biotechnology Research Development 101

GeekWire

JANUARY 14, 2022

The Bill & Melinda Gates Foundation has committed $40 million in equity investment and $10 million in grant funding to Vir Biotechnology for the development of therapies against HIV and Malaria, Vir announced Friday. government has been buying to fight Omicron.

Biotechnology 106

Biotechnology Government Research Development 106

CIO Business Intelligence

JANUARY 2, 2024

That’s the case for Yi Zhou, CTO and CIO with Adaptive Biotechnologies. In today’s dynamic business environment, IT must transcend traditional roles,” Adaptive Biotechnologies’ Zhou says. He plans to scale his company’s experimental generative AI initiatives “and evolve into an AI-native enterprise” in 2024.

Biotechnology 361

Biotechnology Fractional CTO Agile Security 361

GeekWire

SEPTEMBER 26, 2024

Symbl CEO Surbhi Rathore said in a LinkedIn post that Senthivel “has been instrumental in developing foundational infrastructure that serves across industries.” Senthivel was most recently CTO for GE HealthCare and was previously part of AI engineering leadership at Amazon Web Services, among other roles. ” Ken Suzuki.

CTO 109

CTO Healthcare Biotechnology Nonprofit 109

GeekWire

MAY 12, 2020

Adaptive Biotechnologies CEO Chad Robins. Adaptive Biotechnologies, which is working with Microsoft and Amgen to fight COVID-19 using its technology for sequencing the human immune system, reported a 65% increase in first quarter revenue , to nearly $21 million. The goal is to develop therapies to treat the virus.

Biotechnology 112

Biotechnology Pharmaceuticals .Net Microsoft 112

GeekWire

DECEMBER 6, 2021

The news: Seattle-based protein engineering company Cyrus Biotechnology has raised $18 million and acquired Orthogonal Biologics , a spinout from the University of Illinois at Urbana Champaign, which is developing a COVID-19 therapeutic. Cyrus CEO Lucas Nivon. Cyrus Photo).

Software 102

Software Software Development Mobile 102

GeekWire

JULY 8, 2021

Absci, which partners with other biopharma companies to identify and develop protein-based drug candidates, has its roots in Portland. Things are different now, said Alexandre, as companies such as Seagen and Adaptive Biotechnologies go public and grow in the region. Bolstering the workforce, increasing regional connections.

Biotechnology 132

Biotechnology Industry Real Estate Company 132

CIO Business Intelligence

DECEMBER 10, 2024

Where quantum development is, and is heading In the meantime, the United Nations designation recognizes that the current state of quantum science has reached the point where the promise of quantum technology is moving out of the experimental phase and into the realm of practical applications.

Artificial Intelligence 246

Artificial Intelligence Research IBM Industry 246

CTOvision

APRIL 29, 2016

CASI’s research mission is to develop and promote entirely new technologies and novel solutions to complex global challenges in health, sustainability, security and education. ASU researcher improves crop performance with new biotechnology (eurekalert.org). Find more information on ASU's usage of HDP™ to further cancer research here.

Biotechnology 150

Biotechnology Data Research Education 150

GeekWire

FEBRUARY 17, 2021

Notch Therapeutics is commercializing technologies developed in the labs of Juan-Carlos Zúñiga-Pflücker, left, chair of Notch’s scientific advisory board, and Chief Scientific Officer Peter Zandstra. The biotech company was founded in 2018 and is developing stem cell-derived immunotherapies for cancer. Notch Photo).

Biotechnology 122

Biotechnology Pharmaceuticals Research Development 122

GeekWire

FEBRUARY 26, 2021

This was a first-of-its kind diagnostic tool from Seattle-based Adaptive Biotechnologies , a company that develops technology to sequence the human immune system for the diagnosis and treatment of disease. Adaptive Biotechnologies’ new test, called T-Detect COVID , was developed in partnership with Microsoft.

Biotechnology 140

Biotechnology System Study Development 140